Does VEGF-targeted active immunotherapy induce complete abrogation of platelet VEGF levels?

por Sánchez Ramírez, Javier, Bequet-Romero, Mónica, Morera Díaz, Yanelys, Hernández-Bernal, Francisco, Ayala Avila, Marta
Publicado 2019

Active immunization with human interleukin-15 induces neutralizing antibodies in non-human primates

por Rodríguez-Álvarez, Yunier, Morera-Díaz, Yanelys, Gerónimo-Pérez, Haydee, Castro-Velazco, Jorge, Martínez-Castillo, Rafael, Puente-Pérez, Pedro, Besada-Pérez, Vladimir, Hardy-Rando, Eugenio, Chico-Capote, Araceli, Martínez-Cordovez, Klaudia, Santos-Savio, Alicia
Publicado 2016

Evaluation of methodologies to determine the effect of specific active immunotherapy on VEGF levels in phase I clinical trial patients with advanced solid tumors

por Sánchez Ramírez, Javier, Bequet-Romero, Mónica, Morera Díaz, Yanelys, Hernández-Bernal, Francisco, de la Torre Santos, Ana, Selman-Housein Bernal, Katty-Hind, Martín Bauta, Yenima, Bermúdez Badell, Cimara H., Limonta Fernández, Miladys, Ayala Avila, Marta
Publicado 2018

Specific humoral response in cancer patients treated with a VEGF-specific active immunotherapy procedure within a compassionate use program

por Sánchez Ramírez, Javier, Morera Díaz, Yanelys, Bequet-Romero, Mónica, Hernández-Bernal, Francisco, Martín Bauta, Yenima, Selman-Housein Bernal, Katty-Hind, de la Torre Santos, Ana Victoria, Pérez de la Iglesia, Mariela, Trimiño Lorenzo, Lian, Ayala Avila, Marta
Publicado 2020

Characteristics of the specific humoral response in patients with advanced solid tumors after active immunotherapy with a VEGF vaccine, at different antigen doses and using two dis...

por Sánchez Ramírez, Javier, Morera Díaz, Yanelys, Bequet-Romero, Mónica, Hernández-Bernal, Francisco, Selman-Housein Bernal, Katty-Hind, de la Torre Santos, Ana, Santiesteban Álvarez, Eduardo Rafael, Martín Bauta, Yenima, Bermúdez Badell, Cimara H., de la Torre Pupo, Josué, Gavilondo, Jorge V., Ayala Avila, Marta
Publicado 2017